Clinical Trial Update: A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating two doses of MRC375 in adults with moderate to severe rheumatoid arthritis. The status is listed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MRC375

Snippet

Sponsor: Molecular Research Center, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: UNKNOWN